The final rule approved by the Board of Pharmacy that suspends certain requirements regarding closure and minimum hours of operation of prescription drug outlets, consultant pharmacist inspections, and drug therapy management will become effective August 30, 2020. The rule removes certain requirements for sterile compounding and shortages around garbing supplies, eliminates certain requirements for remote practice and hospital satellite pharmacies, and allows pharmacists to administer COVID-19 tests authorized by the FDA.
For more information, contact NACDS’ Mary Staples at 817-442-1155.